Cargando…
Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
American Diabetes Association
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809297/ https://www.ncbi.nlm.nih.gov/pubmed/20103558 http://dx.doi.org/10.2337/dc09-1499 |
| _version_ | 1782176607286329344 |
|---|---|
| author | Drucker, Daniel J. Sherman, Steven I. Gorelick, Fred S. Bergenstal, Richard M. Sherwin, Robert S. Buse, John B. |
| author_facet | Drucker, Daniel J. Sherman, Steven I. Gorelick, Fred S. Bergenstal, Richard M. Sherwin, Robert S. Buse, John B. |
| author_sort | Drucker, Daniel J. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-2809297 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2010 |
| publisher | American Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-28092972011-02-01 Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits Drucker, Daniel J. Sherman, Steven I. Gorelick, Fred S. Bergenstal, Richard M. Sherwin, Robert S. Buse, John B. Diabetes Care Reviews/Commentaries/ADA Statements American Diabetes Association 2010-02 /pmc/articles/PMC2809297/ /pubmed/20103558 http://dx.doi.org/10.2337/dc09-1499 Text en © 2010 by the American Diabetes Association. Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details. |
| spellingShingle | Reviews/Commentaries/ADA Statements Drucker, Daniel J. Sherman, Steven I. Gorelick, Fred S. Bergenstal, Richard M. Sherwin, Robert S. Buse, John B. Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits |
| title | Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits |
| title_full | Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits |
| title_fullStr | Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits |
| title_full_unstemmed | Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits |
| title_short | Incretin-Based Therapies for the Treatment of Type 2 Diabetes: Evaluation of the Risks and Benefits |
| title_sort | incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits |
| topic | Reviews/Commentaries/ADA Statements |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2809297/ https://www.ncbi.nlm.nih.gov/pubmed/20103558 http://dx.doi.org/10.2337/dc09-1499 |
| work_keys_str_mv | AT druckerdanielj incretinbasedtherapiesforthetreatmentoftype2diabetesevaluationoftherisksandbenefits AT shermansteveni incretinbasedtherapiesforthetreatmentoftype2diabetesevaluationoftherisksandbenefits AT gorelickfreds incretinbasedtherapiesforthetreatmentoftype2diabetesevaluationoftherisksandbenefits AT bergenstalrichardm incretinbasedtherapiesforthetreatmentoftype2diabetesevaluationoftherisksandbenefits AT sherwinroberts incretinbasedtherapiesforthetreatmentoftype2diabetesevaluationoftherisksandbenefits AT busejohnb incretinbasedtherapiesforthetreatmentoftype2diabetesevaluationoftherisksandbenefits |